What does APOTHEEK SCARPHOUT do?

APOTHEEK SCARPHOUT is a pharmacy in Blankenberge. Private Limited, started on 1 October 1981, 1 establishment.

What is the address of APOTHEEK SCARPHOUT?

The registered office of APOTHEEK SCARPHOUT is located at J. de Troozlaan 91, 8370 Blankenberge.

Is APOTHEEK SCARPHOUT still active?

Yes. According to the CBE (29 October 2026) APOTHEEK SCARPHOUT is active, legal situation “Normale toestand”, started on 1 October 1981.

Is APOTHEEK SCARPHOUT registered on Peppol?

Yes, APOTHEEK SCARPHOUT is registered on the Peppol network with ID 0208:0421970586.

What is the enterprise number of APOTHEEK SCARPHOUT?

The enterprise number of APOTHEEK SCARPHOUT is BE0421970586.

When was APOTHEEK SCARPHOUT founded?

APOTHEEK SCARPHOUT was founded on 1 October 1981.

Who are the directors of APOTHEEK SCARPHOUT?

According to the 2025 annual accounts, the directors of APOTHEEK SCARPHOUT are: Sodiap BV, Alexo BV.

Is APOTHEEK SCARPHOUT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 October 1981; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK SCARPHOUT make in 2025?

APOTHEEK SCARPHOUT posted a profit after taxes of € 46,725 in financial year 2025.

What is the revenue of APOTHEEK SCARPHOUT?

As a small company, APOTHEEK SCARPHOUT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 207,236.

How much does an employee at APOTHEEK SCARPHOUT earn?

The average wage cost per full-time employee at APOTHEEK SCARPHOUT was € 77,800 in 2025: staff costs of € 85,587 for 1.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK SCARPHOUT have?

According to the 2025 annual accounts, APOTHEEK SCARPHOUT has 1.1 full-time equivalents (FTE).

APOTHEEK SCARPHOUT (Private Limited) - Blankenberge

Dossier APOTHEEK SCARPHOUT, printed on 29 October 2026 from databakkes.be/en/0421970586/apotheek-scarphout. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK SCARPHOUT from Blankenberge, company number BE0421970586, closed financial year 2025 with a result of € 46,725 after tax. For that financial year APOTHEEK SCARPHOUT recorded a gross margin of € 207,236 and equity of € 463,825. Compared with financial year 2024, the result moved from € 19,327 to € 46,725. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Growing

€ 463,825

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 46,725

▲ 142% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,363

▼ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 13,825.

People and assets in 2025

Full-time equivalents

1.1

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 85,587

▼ 21% vs 2024

€ 77,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,438

▼ 2% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 74,112

▼ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 20,245

▲ 58% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 228,948 Gross margin 2022: € 228,948 First fiscal year in the series	€ 199,000 Gross margin 2023: € 199,000 ▼ 13% vs 2022 (€ 228,948) Unfavourable step	€ 199,119 Gross margin 2024: € 199,119 Unchanged (€ 199,000) Favourable step	€ 207,236 Gross margin 2025: € 207,236 ▲ 4% vs 2024 (€ 199,119) Favourable step	▲ 4%
Profit after taxes	€ 97,973 Profit after taxes 2022: € 97,973 First fiscal year in the series	€ 33,168 Profit after taxes 2023: € 33,168 ▼ 66% vs 2022 (€ 97,973) Unfavourable step	€ 19,327 Profit after taxes 2024: € 19,327 ▼ 42% vs 2023 (€ 33,168) Unfavourable step	€ 46,725 Profit after taxes 2025: € 46,725 ▲ 142% vs 2024 (€ 19,327) Favourable step	▲ 142%
Equity	€ 364,606 Equity 2022: € 364,606 First fiscal year in the series	€ 397,773 Equity 2023: € 397,773 ▲ 9% vs 2022 (€ 364,606) Favourable step	€ 417,100 Equity 2024: € 417,100 ▲ 5% vs 2023 (€ 397,773) Favourable step	€ 463,825 Equity 2025: € 463,825 ▲ 11% vs 2024 (€ 417,100) Favourable step	▲ 11%
Total debts	€ 394,980 Total debts 2022: € 394,980 First fiscal year in the series	€ 546,064 Total debts 2023: € 546,064 ▲ 38% vs 2022 (€ 394,980) Unfavourable step	€ 481,518 Total debts 2024: € 481,518 ▼ 12% vs 2023 (€ 546,064) Favourable step	€ 407,765 Total debts 2025: € 407,765 ▼ 15% vs 2024 (€ 481,518) Favourable step	▼ 15%
Cash	€ 8,837 Cash 2022: € 8,837 First fiscal year in the series	€ 8,283 Cash 2023: € 8,283 ▼ 6% vs 2022 (€ 8,837) Unfavourable step	€ 13,505 Cash 2024: € 13,505 ▲ 63% vs 2023 (€ 8,283) Favourable step	€ 10,363 Cash 2025: € 10,363 ▼ 23% vs 2024 (€ 13,505) Unfavourable step	▼ 23%
Land & buildings	€ 529,421 Land & buildings 2022: € 529,421 First fiscal year in the series	€ 511,739 Land & buildings 2023: € 511,739 ▼ 3% vs 2022 (€ 529,421) Unchanged	€ 494,057 Land & buildings 2024: € 494,057 ▼ 3% vs 2023 (€ 511,739) Unchanged	€ 476,375 Land & buildings 2025: € 476,375 ▼ 4% vs 2024 (€ 494,057) Unchanged	▼ 4%
Retained profit	€ -85,394 Retained profit 2022: € -85,394 First fiscal year in the series	€ -52,227 Retained profit 2023: € -52,227 ▲ € 33,168 vs 2022 (€ -85,394) Favourable step	€ -32,900 Retained profit 2024: € -32,900 ▲ € 19,327 vs 2023 (€ -52,227) Favourable step	€ 13,825 Retained profit 2025: € 13,825 ▲ € 46,725 vs 2024 (€ -32,900) Favourable step	▲ € 46,725
Balance sheet total	€ 759,585 Balance sheet total 2022: € 759,585 First fiscal year in the series	€ 943,837 Balance sheet total 2023: € 943,837 ▲ 24% vs 2022 (€ 759,585) Unchanged	€ 898,619 Balance sheet total 2024: € 898,619 ▼ 5% vs 2023 (€ 943,837) Unchanged	€ 871,589 Balance sheet total 2025: € 871,589 ▼ 3% vs 2024 (€ 898,619) Unchanged	▼ 3%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1 Employees (FTE) 2023: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2024: 1 Unchanged (1) Unchanged	1.1 Employees (FTE) 2025: 1.1 ▲ 0.1 vs 2024 (1) Unchanged	▲ 0.1

Key figures of APOTHEEK SCARPHOUT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK SCARPHOUT?

What happened at APOTHEEK SCARPHOUT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 12, 2026 New annual accounts for financial year 2025: profit of € 46,725 (▲ 142% vs 2024). Source: NBB ↗
2022 Alexo BV became a director. NBB
2020 Sodiap BV became a director. NBB
Oct 1, 1981 New establishment in Blankenberge. KBO
Oct 1, 1981 Start of the company according to the CBE. KBO

In short

From € 97,973 profit in 2022 to € 46,725 profit in 2025.

Paid € 9,795 in corporate taxes since 2022.

Best year ever: 2022, with € 97,973 profit.

On average € 188,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

SODIAP 100%

The stake of SODIAP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK SCARPHOUT

Behind APOTHEEK SCARPHOUT are Sodiap BV and Alexo BV. The shares are held by SODIAP (100%).

Directors

According to the 2025 annual accounts

Sodiap BV

Managing director · represented by Tom Goderis

Also active at: SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg, Apotheek Seurinck, C.E. FARMA, SANIFAR, WENDUINE PHARMA +24 more

since 2020

Alexo BV

Chairman of the board · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP, APOTHEEK JENNE, PANNOC CHEMIE, Apotheek de Lisseweg, Apotheek Seurinck, C.E. FARMA +34 more

since 2022

Shareholders

SODIAP

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

J. de Troozlaan 91

8370 Blankenberge

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0421.970.586

VAT number

BE 0421.970.586

Registered office

J. de Troozlaan 91, 8370 Blankenberge

Names & denominations

APOTHEEK SCARPHOUT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 October 1981

Peppol

Active · Active since 6 Jun 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK SCARPHOUT

Warning lights

Financials

What happened to APOTHEEK SCARPHOUT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions